Investor Presentaiton

Biologically rich data [000000] XXXXXX XXXXXX Mutations Chromosomal rearrangements Copy number aberrations -CH3 Methylation XXXXXXX XXXXXXX XXXXXXXXXXXX CH3 XXXXXX DNA fragment lengths INVESTOR 20 DAY 23 Comprehensive longitudinal characterization of tumor, whole body epigenomic profiles and immune response TSS Read depth coverage (tumor) Gene expression NNNNNNNNNA XXXXXX Virus sequences detection GUARDANT™ Figure from https://www.nature.com/articles/s41416-020-01047-5 Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond 157

View entire presentation